According to Straits Research, the Companion Diagnostics for Oncology Market is witnessing significant growth due to the increasing adoption of precision medicine, rising cancer incidence, and technological advancements in biomarker testing. The market is projected to grow at a substantial CAGR during the forecast period, driven by innovations in next-generation sequencing (NGS),... https://straitsresearch.com/report/companion-diagnostics-for-oncology-market